Detection of serum and intrahepatic hepatocyte growth factor in hepatocellular carcinoma.

被引：0
|
作者：
Komine, F
Moriyama, M
Hayashi, N
Suzuki, K
Tanaka, N
Ohkubo, H
Ishizuka, H
Arakawa, Y
Sugitani, M
Uchida, T
机构：
[1] NIHON UNIV, SCH MED, DEPT PATHOL 1, TOKYO, JAPAN
[2] NIHON UNIV, SCH MED, DEPT INTERNAL MED 3, TOKYO, JAPAN
来源：
GASTROENTEROLOGY | 1996年 / 110卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A1239 / A1239
页数：1
相关论文
共 50 条
  • [41] Serum Transforming Growth Factor α in Liver Cirrhosis and Hepatocellular Carcinoma
    M K Zahra
    Th S Badawy
    S A Ismail
    S F El-Shazly
    Pediatric Research, 1999, 45 : 775 - 775
  • [42] Hepatocellular carcinoma.
    Lemoine, A
    Azoulay, D
    Jezequel-Cuer, M
    Debuire, B
    PATHOLOGIE BIOLOGIE, 1999, 47 (09): : 903 - 910
  • [43] Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma
    Price, JA
    Kovach, SJ
    Johnson, T
    Koniaris, LG
    Cahill, PA
    Sitzmann, JV
    McKillop, LH
    HEPATOLOGY, 2002, 36 (05) : 1089 - 1097
  • [44] Hepatocellular carcinoma.
    Venook A.P.
    Current Treatment Options in Oncology, 2000, 1 (5) : 407 - 414
  • [45] Differential expression of insulin-like growth factor II mRNA in hepatocellular carcinoma.
    Ng, IOL
    Lee, JMF
    Srivastava, G
    GASTROENTEROLOGY, 1996, 110 (04) : A1277 - A1277
  • [46] The measurement of human hepatocytes growth factor in the blood is useful for predicting the occurrence of hepatocellular carcinoma.
    Yamagami, H
    Moriyama, M
    Matsumura, H
    Kaneko, M
    Shioda, A
    Tanaka, N
    Arakawa, Y
    HEPATOLOGY, 2001, 34 (04) : 220A - 220A
  • [47] A gene mutation of transforming growth factor β 1 type II receptor in hepatocellular carcinoma.
    Takahashi, K
    Furuta, K
    Misao, S
    Tagaya, T
    Fukuzawa, Y
    Sugiyama, H
    Kakumu, S
    HEPATOLOGY, 1998, 28 (04) : 413A - 413A
  • [48] Changes of epidermal growth factor in sera of the patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Lee, DH
    Lee, SH
    Kim, HJ
    Kim, BH
    Oh, SJ
    Kim, TY
    Cho, YJ
    Kim, JM
    Cho, YH
    HEPATOLOGY, 1996, 24 (04) : 1641 - 1641
  • [49] Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma.
    von Marschall, Z
    Cramer, T
    Hoecker, M
    Wiedenmann, B
    Rosewicz, S
    GASTROENTEROLOGY, 2000, 118 (04) : A562 - A562
  • [50] Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma
    T Fukuura
    C Miki
    T Inoue
    K Matsumoto
    H Suzuki
    British Journal of Cancer, 1998, 78 : 454 - 459
12345